$31.16
1.08%
Nasdaq, Sep 30, 04:00 pm EDT.
ISIN
US63009J1079
Symbol
NBTX

Nanobiotix - ADR Target price 2026 - Analyst rating & recommendation

Nanobiotix - ADR Classifications & Recommendation

Buy
83%
Hold
17%

Nanobiotix - ADR Price Target

Target Price $53.75
Price $31.16
Potential
Number of Estimates 8
8 Analysts have issued a price target Nanobiotix - ADR 2027 . The average Nanobiotix - ADR target price is $53.75. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 10 Analysts recommend Nanobiotix - ADR to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Nanobiotix - ADR stock has an average upside potential 2027 of . Most analysts recommend the Nanobiotix - ADR stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Million $ 8.89 46.40
167.60% 421.91%
EBITDA Margin -399.33% -39.30%
169.40% 90.16%
Net Margin -305.40% -68.41%
152.02% 77.60%

7 Analysts have issued a sales forecast Nanobiotix - ADR 2026 . The average Nanobiotix - ADR sales estimate is

$46.4m
unlock
. This is
421.91% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$78.7m 785.63%
unlock
, the lowest is
$25.5m 187.30%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $8.9m 167.60%
2026
$46.4m 421.91%
unlock
2027
$75.9m 63.56%
unlock
2028
$147m 93.55%
unlock
2029
$76.8m 47.74%
unlock
2030
$124m 62.19%
unlock
2031
$375m 201.58%
unlock
2032
$505m 34.61%
unlock
2033
$758m 49.89%
unlock

6 Analysts have issued an Nanobiotix - ADR EBITDA forecast 2026. The average Nanobiotix - ADR EBITDA estimate is

$-18.2m
unlock
. This is
48.51% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-3.6m 89.92%
unlock
, the lowest is
$-27.7m 21.91%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-35.5m 53.09%
2026
$-18.2m 48.64%
unlock
2027
$8.8m 148.02%
unlock
2028
$71.1m 711.83%
unlock
2029
$-57.8m 181.34%
unlock
2030
$-62.9m 8.76%
unlock

EBITDA Margin

2025 -399.33% 169.40%
2026
-39.30% 90.16%
unlock
2027
11.54% 129.36%
unlock
2028
48.40% 319.41%
unlock
2029
-75.33% 255.64%
unlock
2030
-50.51% 32.95%
unlock

7 Nanobiotix - ADR Analysts have issued a net profit forecast 2026. The average Nanobiotix - ADR net profit estimate is

$-31.7m
unlock
. This is
16.91% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-9.2m 66.08%
unlock
, the lowest is
$-48.9m 80.11%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-27.2m 64.83%
2026
$-31.7m 16.91%
unlock
2027
$-30.8m 3.09%
unlock
2028
$46.6m 251.53%
unlock
2029
$14.5m 68.83%
unlock
2030
$38.2m 162.77%
unlock
2031
$190m 398.61%
unlock
2032
$229m 20.12%
unlock
2033
$394m 72.49%
unlock

Net Margin

2025 -305.40% 152.02%
2026
-68.41% 77.60%
unlock
2027
-40.54% 40.74%
unlock
2028
31.73% 178.27%
unlock
2029
18.93% 40.34%
unlock
2030
30.67% 62.02%
unlock
2031
50.71% 65.34%
unlock
2032
45.25% 10.77%
unlock
2033
52.07% 15.07%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share $ -0.57 -0.66
65.03% 15.79%
P/E negative
EV/Sales 35.16

7 Analysts have issued a Nanobiotix - ADR forecast for earnings per share. The average Nanobiotix - ADR EPS is

$-0.66
unlock
. This is
15.79% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-0.19 66.67%
unlock
, the lowest is
$-1.01 77.19%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.57 65.03%
2026
$-0.66 15.79%
unlock
2027
$-0.64 3.03%
unlock
2028
$0.96 250.00%
unlock
2029
$0.30 68.75%
unlock
2030
$0.79 163.33%
unlock
2031
$3.93 397.47%
unlock
2032
$4.73 20.36%
unlock
2033
$8.15 72.30%
unlock

P/E ratio

Current -54.67 468.88%
2026
-47.51 13.09%
unlock
2027
-49.02 3.18%
unlock
2028
32.35 165.99%
unlock
2029
103.77 220.77%
unlock
2030
39.49 61.94%
unlock
2031
7.92 79.94%
unlock
2032
6.59 16.79%
unlock
2033
3.82 42.03%
unlock

Based on analysts' sales estimates for 2026, the Nanobiotix - ADR stock is valued at an EV/Sales of

35.16
unlock
and an P/S ratio of
34.12
unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 183.51 448.28%
2026
35.16 80.84%
unlock
2027
21.50 38.86%
unlock
2028
11.11 48.33%
unlock
2029
21.25 91.37%
unlock
2030
13.10 38.35%
unlock
2031
4.35 66.84%
unlock
2032
3.23 25.71%
unlock
2033
2.15 33.28%
unlock

P/S ratio

Current
2026
34.12 80.84%
unlock
2027
20.86 38.86%
unlock
2028
10.78 48.33%
unlock
2029
20.63 91.37%
unlock
2030
12.72 38.35%
unlock
2031
4.22 66.84%
unlock
2032
3.13 25.71%
unlock
2033
2.09 33.28%
unlock

Current Nanobiotix - ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
STIFEL EUROPE
Locked
➜
Locked
Locked Sep 14 2026
ODDO BHF
Locked
➜
Locked
Locked Sep 14 2026
JEFFERIES
Locked
➜
Locked
Locked Sep 14 2026
STIFEL EUROPE
Locked
➜
Locked
Locked Jun 03 2026
ODDO BHF
Locked
➜
Locked
Locked Jun 03 2026
STIFEL EUROPE
Locked
➜
Locked
Locked Jun 02 2026
ODDO BHF
Locked
➜
Locked
Locked Jun 02 2026
Analyst Rating Date
Locked
STIFEL EUROPE:
Locked
➜
Locked
Sep 14 2026
Locked
ODDO BHF:
Locked
➜
Locked
Sep 14 2026
Locked
JEFFERIES:
Locked
➜
Locked
Sep 14 2026
Locked
STIFEL EUROPE:
Locked
➜
Locked
Jun 03 2026
Locked
ODDO BHF:
Locked
➜
Locked
Jun 03 2026
Locked
STIFEL EUROPE:
Locked
➜
Locked
Jun 02 2026
Locked
ODDO BHF:
Locked
➜
Locked
Jun 02 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today